Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Emma Walmsley Insider Profile
11 Followers
Emma Walmsley, Chief Executive Officer at GlaxoSmithKline, holds 42.09M shares in GlaxoSmithKline (Ticker: GB:GSK).
Emma Walmsley GlaxoSmithKline (GSK)Chief Executive Officer
GlaxoSmithKline (GSK)
Chief Executive Officer
Ranked #54,430 out of 98,384 Corporate Insiders
Profitable Transactions
11 out of 18 Profitable Transactions
Average Return
-1.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Executive Officer
Roles that Emma Walmsley holds in companies
Most Profitable Insider Trade
The most profitable trade made by Emma Walmsley
Emma Walmsley's Trading History
List of latest transactions for each holding click on a transaction to see Emma Walmsley's performance on stock
You May Also Like
Emma Walmsley insider profile FAQ
What is the percentage of profitable transactions made by Emma Walmsley?
The percentage of profitable transactions made by Emma Walmsley is 61%.
What is the average return per transaction made by Emma Walmsley?
The average return per transaction made by Emma Walmsley is -1.50%.
What stocks does Emma Walmsley hold?
Emma Walmsley holds: GB:GSK stocks.
What was Emma Walmsley’s latest transaction?
Emma Walmsley latest transaction was an Uninformative Buy of ―.
What was Emma Walmsley's most profitable transaction?
Emma Walmsley’s most profitable transaction was an Informative Sell of GB:GSK stock on November 1, 2019. The return on the trade was 23.00%.
What is Emma Walmsley's role in GlaxoSmithKline?
Emma Walmsley's role in GlaxoSmithKline is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.